Depression Mental and Behavioural Disorders
Conditions
Interventions
Participants are randomised to one of three study arms by specific software.
Study arm 1: Intervention Group (bouldering psychotherapy)
Participants receive therapy in groups of ten led by two psycho
Sponsors
Universitätsklinikum Erlangen
Eligibility
Inclusion criteria
Inclusion criteria: 1. Depression, diagnosed by a diagnostic interview based on the DSM-V diagnostic criteria. 2. Informed consent to participate in the study (especially regarding the randomised allocation and data acquisition) 3. Possibility to come to the therapy locations and time capacities to participate in the interventions.
Exclusion criteria
Exclusion criteria: 1. Age 40 kg/m²) 4. Current treatment that confounds with study outcomes (participation in psycho-therapeutic group therapy; initiation of psychiatric medication in the 8 weeks prior to the start of the intervention)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Depression is measured using the score of an observer-rating scale (Montgomery Asberg Rating Scale, MADRS) by computer-assisted video interviews at baseline, within two weeks after the intervention and 12 months after the intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Anxiety is measured using the Generalized Anxiety Disorder Scale-7 (GAD-7) at baseline, within two weeks after the intervention and 12 months after the intervention. 2. Self-efficacy is measured using the ‘Skala zur Allgemeinen Selbstwirksamkeit’ (SWE) at baseline, within two weeks after the intervention and 12 months after the intervention. 3. The Sense of Coherence is measured using the short version of the ‘Sense of Coherence scale’ (SOC) at baseline, within two weeks after the intervention and 12 months after the intervention. 4. The Locus of Control is measured using the ‘Internal External Locus of Control’ (IE-4) at baseline, within two weeks after the intervention and 12 months after the intervention. 5. The body-based mindfulness is measured using the ‘State Mindfulness Scale for Physical Activity’ (SMS-PA-12) at baseline, within two weeks after the intervention and 12 months after the intervention. 6. Mindfulness state is measured using the ‘Multidimensional State Mindfulness Questionnaire’ (MSMQ) at baseline, within two weeks after the intervention and 12 months after the intervention. 7. Physical activity is measured using the ‘BSA-Questionnaire’ (BSA-F) at baseline, within two weeks after the intervention and 12 months after the intervention. 8. Hand strength is measured using the ‘Baseline Hydraulic Hand Dynamometer’ at baseline and within two weeks after the intervention. 9. Core stability is measured using McGill’s ‘Torso muscular endurance test battery’ at baseline and within two weeks after the intervention. 10. The blood concentration of osteocalcin is measured using ELISA at baseline and within two weeks after the intervention 11. Age, gender, height and weight (BMI), occupation, actual treatment (medication/psychotherapy), previous treatment, therapy preferences and experiences with meditation are detected by using open questions at baseline. 12. Changes concerning actual treatment (medication/psychotherapy) are detected by using open question | — |
Countries
Germany
Outcome results
None listed